Differential contractile response of critically ill patients to neuromuscular electrical stimulation

Julius J Grunow, Moritz Goll, Niklas M Carbon, Max E Liebl, Steffen Weber-Carstens, Tobias Wollersheim, Julius J Grunow, Moritz Goll, Niklas M Carbon, Max E Liebl, Steffen Weber-Carstens, Tobias Wollersheim

Abstract

Background: Neuromuscular electrical stimulation (NMES) has been investigated as a preventative measure for intensive care unit-acquired weakness. Trial results remain contradictory and therefore inconclusive. As it has been shown that NMES does not necessarily lead to a contractile response, our aim was to characterise the response of critically ill patients to NMES and investigate potential outcome benefits of an adequate contractile response.

Methods: This is a sub-analysis of a randomised controlled trial investigating early muscle activating measures together with protocol-based physiotherapy in patients with a SOFA score ≥ 9 within the first 72 h after admission. Included patients received protocol-based physiotherapy twice daily for 20 min and NMES once daily for 20 min, bilaterally on eight muscle groups. Electrical current was increased up to 70 mA or until a contraction was detected visually or on palpation. Muscle strength was measured by a blinded assessor at the first adequate awakening and ICU discharge.

Results: One thousand eight hundred twenty-four neuromuscular electrical stimulations in 21 patients starting on day 3.0 (2.0/6.0) after ICU admission were included in this sub-analysis. Contractile response decreased from 64.4% on day 1 to 25.0% on day 7 with a significantly lower response rate in the lower extremities and proximal muscle groups. The electrical current required to elicit a contraction did not change over time (day 1, 50.2 [31.3/58.8] mA; day 7, 45.3 [38.0/57.5] mA). The electrical current necessary for a contractile response was higher in the lower extremities. At the first awakening, patients presented with significant weakness (3.2 [2.5/3.8] MRC score). When dividing the cohort into responders and non-responders (> 50% vs. ≤ 50% contractile response), we observed a significantly higher SOFA score in non-responders. The electrical current necessary for a muscle contraction in responders was significantly lower (38.0 [32.8/42.9] vs. 54.7 [51.3/56.0] mA, p < 0.001). Muscle strength showed higher values in the upper extremities of responders at ICU discharge (4.4 [4.1/4.6] vs. 3.3 [2.8/3.8] MRC score, p = 0.036).

Conclusion: Patients show a differential contractile response to NMES, which appears to be dependent on the severity of illness and also relevant for potential outcome benefits.

Trial registration: ISRCTN ISRCTN19392591 , registered 17 February 2011.

Keywords: Critical illness; Critical illness myopathy; Early mobilisation; Intensive care unit-acquired weakness; Neuromuscular electrical stimulation.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Relative contractile response, electrical current and muscle strength during NMES. a Relative contractile response decreases between day 1 and day 7 without reaching statistical significance. b Upper extremities show a significantly higher response rate to NMES on days 1, 2, 3, 4, 5 and 7 in comparison to lower extremities. c Muscle strength and contractile response for all muscle groups separately. M. vastus lateralis shows the lowest response to NMES. d Electrical current required to elicit a muscle contraction remains unchanged between day 1 and day 7. e A significant difference in electrical current required to elicit a muscle contraction can be observed on days 2, 3, 4, 5 and 6 when comparing upper and lower extremities. f Muscle strength increase for both extremities between first awakening and ICU discharge does not reach statistical significance. g The increase in muscle strength between first awakening and ICU discharge reaches statistical significance for lower extremities. All values are shown as median and interquartile range. Statistical significance was calculated via Mann-Whitney U test or Wilcoxon signed-rank test as appropriate. A p < 0.05 is indicated by "+" in b and e. ICU = intensive care unit; MRC = Medical research council
Fig. 2
Fig. 2
Relative contractile response, electrical current and muscle strength in comparison between responders and non-responders. Relative contractile response is significantly higher in responders as opposed to non-responders during the first 7 days after ICU admission a for both extremities, b for upper extremities, c for lower extremities and d for all muscle groups separately. Electrical current required to elicit a contractile response is significantly higher in non-responders as opposed to responders during the first 7 days after ICU admission e for both extremities and f for upper extremities, while no difference can be observed for g lower extremities. Muscle strength measured via MRC scored at ICU discharge shows significantly higher values in responders as opposed non-responders for i upper extremities, while not reaching statistical difference for h both extremities as well as j lower extremities at first adequate awakening as well as ICU discharge and h upper extremities at first adequate awakening. All values are shown as median and interquartile range. Statistical significance was calculated via Mann-Whitney U test or Wilcoxon signed-rank test as appropriate. MRC = Medical research council
Fig. 3
Fig. 3
Muscle strength at first adequate awakening and ICU discharge for all muscle groups separately. Muscle strength difference measured via MRC score at a first awakening and b ICU discharge in responders and non-responders. MRC = Medical research council
Fig. 4
Fig. 4
Correlation and ROC curve for contractile response and SOFA. Relative contractile response between days 1 and 7 correlates with a SOFA score. b ROC curve for SOFA score in patients with adequate contractile response to neuromuscular electrical stimulation. SOFA = Sepsis-related Organ Failure Assessment; ROC = receiver operating characteristics

References

    1. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348(8):683–693. doi: 10.1056/NEJMoa022450.
    1. Cheung AM, Tansey CM, Tomlinson G, Diaz-Granados N, Matte A, Barr A, et al. Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2006;174(5):538–544. doi: 10.1164/rccm.200505-693OC.
    1. Fan E, Dowdy DW, Colantuoni E, Mendez-Tellez PA, Sevransky JE, Shanholtz C, et al. Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med. 2014;42(4):849–859. doi: 10.1097/CCM.0000000000000040.
    1. Hermans G, Van Mechelen H, Clerckx B, Vanhullebusch T, Mesotten D, Wilmer A, et al. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014;190(4):410–420. doi: 10.1164/rccm.201312-2257OC.
    1. Kamdar BB, Huang M, Dinglas VD, Colantuoni E, von Wachter TM, Hopkins RO, et al. Joblessness and lost earnings after acute respiratory distress syndrome in a 1-year national multicenter study. Am J Respir Crit Care Med. 2017;196(8):1012–1020. doi: 10.1164/rccm.201611-2327OC.
    1. Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369(14):1306–1316. doi: 10.1056/NEJMoa1301372.
    1. Jackson JC, Pandharipande PP, Girard TD, Brummel NE, Thompson JL, Hughes CG, et al. Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study. Lancet Respir Med. 2014;2(5):369–379. doi: 10.1016/S2213-2600(14)70051-7.
    1. Norman BC, Jackson JC, Graves JA, Girard TD, Pandharipande PP, Brummel NE, et al. Employment outcomes after critical illness: an analysis of the bringing to light the risk factors and incidence of neuropsychological dysfunction in ICU survivors cohort. Crit Care Med. 2016;44(11):2003–2009. doi: 10.1097/CCM.0000000000001849.
    1. Herridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-Granados N, Cooper A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364(14):1293–1304. doi: 10.1056/NEJMoa1011802.
    1. Schaller SJ, Anstey M, Blobner M, Edrich T, Grabitz SD, Gradwohl-Matis I, et al. Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trial. Lancet. 2016;388(10052):1377–1388. doi: 10.1016/S0140-6736(16)31637-3.
    1. Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373(9678):1874–1882. doi: 10.1016/S0140-6736(09)60658-9.
    1. Morris PE, Berry MJ, Files DC, Thompson JC, Hauser J, Flores L, et al. Standardized rehabilitation and hospital length of stay among patients with acute respiratory failure: a randomized clinical trial. JAMA. 2016;315(24):2694–2702. doi: 10.1001/jama.2016.7201.
    1. Fossat G, Baudin F, Courtes L, Bobet S, Dupont A, Bretagnol A, et al. Effect of in-bed leg cycling and electrical stimulation of the quadriceps on global muscle strength in critically ill adults: a randomized clinical trial. JAMA. 2018;320(4):368–378. doi: 10.1001/jama.2018.9592.
    1. Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolis T, Tripodaki E, et al. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care. 2010;14(2):R74. doi: 10.1186/cc8987.
    1. Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, et al. Acute skeletal muscle wasting in critical illness. JAMA. 2013;310(15):1591–1600. doi: 10.1001/jama.2013.278481.
    1. Wollersheim T, Woehlecke J, Krebs M, Hamati J, Lodka D, Luther-Schroeder A, et al. Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness. Intensive Care Med. 2014;40(4):528–538. doi: 10.1007/s00134-014-3224-9.
    1. Rodriguez PO, Setten M, Maskin LP, Bonelli I, Vidomlansky SR, Attie S, et al. Muscle weakness in septic patients requiring mechanical ventilation: protective effect of transcutaneous neuromuscular electrical stimulation. J Crit Care. 2012;27(3):319. doi: 10.1016/j.jcrc.2011.04.010.
    1. Segers J, Hermans G, Bruyninckx F, Meyfroidt G, Langer D, Gosselink R. Feasibility of neuromuscular electrical stimulation in critically ill patients. J Crit Care. 2014;29(6):1082–1088. doi: 10.1016/j.jcrc.2014.06.024.
    1. Wollersheim Tobias, Grunow Julius J., Carbon Niklas M., Haas Kurt, Malleike Johannes, Ramme Sara F., Schneider Joanna, Spies Claudia D., Märdian Sven, Mai Knut, Spuler Simone, Fielitz Jens, Weber‐Carstens Steffen. Muscle wasting and function after muscle activation and early protocol‐based physiotherapy: an explorative trial. Journal of Cachexia, Sarcopenia and Muscle. 2019;10(4):734–747. doi: 10.1002/jcsm.12428.
    1. Spies C, Kastrup M, Thoralf K, Melzer-Gratzke C, Zielke H, Wolfgang K. SOPs in Intensivmedizin Und Notfallmedizin: Alle Relevanten Standards Und Techniken Für Die Klinik. 1. Auflage ed: Thieme; 2014.
    1. Weber-Carstens S, Koch S, Spuler S, Spies CD, Bubser F, Wernecke KD, et al. Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients. Crit Care Med. 2009;37(9):2632–2637. doi: 10.1097/CCM.0b013e3181a92f28.
    1. Karatzanos E, Gerovasili V, Zervakis D, Tripodaki ES, Apostolou K, Vasileiadis I, et al. Electrical muscle stimulation: an effective form of exercise and early mobilization to preserve muscle strength in critically ill patients. Crit Care Res Pract. 2012;2012:432752.
    1. Kho ME, Truong AD, Zanni JM, Ciesla ND, Brower RG, Palmer JB, et al. Neuromuscular electrical stimulation in mechanically ventilated patients: a randomized, sham-controlled pilot trial with blinded outcome assessment. J Crit Care. 2015;30(1):32–39. doi: 10.1016/j.jcrc.2014.09.014.
    1. Connolly B, Maddocks M, MacBean V, Bernal W, Hart N, Hopkins P, et al. Nonvolitional assessment of tibialis anterior force and architecture during critical illness. Muscle Nerve. 2018;57(6):964–972. doi: 10.1002/mus.26049.
    1. Dos Santos C, Hussain SN, Mathur S, Picard M, Herridge M, Correa J, et al. Mechanisms of chronic muscle wasting and dysfunction after an intensive care unit stay. A pilot study. Am J Respir Crit Care Med. 2016;194(7):821–830. doi: 10.1164/rccm.201512-2344OC.
    1. Puthucheary ZA, Astin R, McPhail MJW, Saeed S, Pasha Y, Bear DE, et al. Metabolic phenotype of skeletal muscle in early critical illness. Thorax. 2018;73(10):926–935. doi: 10.1136/thoraxjnl-2017-211073.
    1. Patsaki I, Gerovasili V, Sidiras G, Karatzanos E, Mitsiou G, Papadopoulos E, et al. Effect of neuromuscular stimulation and individualized rehabilitation on muscle strength in intensive care unit survivors: a randomized trial. J Crit Care. 2017;40:76–82. doi: 10.1016/j.jcrc.2017.03.014.
    1. Fischer A, Spiegl M, Altmann K, Winkler A, Salamon A, Themessl-Huber M, et al. Muscle mass, strength and functional outcomes in critically ill patients after cardiothoracic surgery: does neuromuscular electrical stimulation help? The Catastim 2 randomized controlled trial. Crit Care. 2016;20:30. doi: 10.1186/s13054-016-1199-3.
    1. Parry SM, Berney S, Warrillow S, El-Ansary D, Bryant AL, Hart N, et al. Functional electrical stimulation with cycling in the critically ill: a pilot case-matched control study. J Crit Care. 2014;29(4):695. doi: 10.1016/j.jcrc.2014.03.017.
    1. Weber-Carstens S, Deja M, Koch S, Spranger J, Bubser F, Wernecke KD, et al. Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care. 2010;14(3):R119. doi: 10.1186/cc9074.
    1. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288(22):2859–2867. doi: 10.1001/jama.288.22.2859.
    1. Fan E, Cheek F, Chlan L, Gosselink R, Hart N, Herridge MS, et al. An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med. 2014;190(12):1437–1446. doi: 10.1164/rccm.201411-2011ST.
    1. Jiroutkova K, Krajcova A, Ziak J, Fric M, Waldauf P, Dzupa V, et al. Mitochondrial function in skeletal muscle of patients with protracted critical illness and ICU-acquired weakness. Crit Care. 2015;19:448. doi: 10.1186/s13054-015-1160-x.

Source: PubMed

3
Abonnieren